首页> 外文期刊>Journal of the American Chemical Society >Development of a Modular Synthetic Route to (+)-Pleuromutilin, (+)-12-epi-Mutilins, and Related Structures
【24h】

Development of a Modular Synthetic Route to (+)-Pleuromutilin, (+)-12-epi-Mutilins, and Related Structures

机译:模块化合成路线发展到(+)-截短侧耳素,(+)-12-表位-远侧肠素和相关结构

获取原文
获取原文并翻译 | 示例
           

摘要

We describe the development of an enantioselective synthetic route to (+)-pleuromutilin (1), (+)-12-epi-mutilin, and related derivatives. A key hydrindanone was prepared in three steps and 48% overall yield from cyclohex-2-en-1-one. 1,4-Hydrocyanation provided a nitrile (53%, or 85% based on recovered starting material) that was converted to the eneimide 57 in 80% yield by the 1,2-addition of methyllithium to the nitrile function, cyclization, and in situ acylation with di-tert-butyldicarbonate. The eneimide 57 was employed in a 2-fold neopentylic coupling reaction with an organolithium reagent derived from the alkyl iodides (R)- or (S)-30, which contain the C11-C13 atoms of the target, to provide diastereomeric diketones in 60% or 48% yield (for coupling with (R)- or (S)-30, respectively). The diketone derived from (S)-30 contains the (S)-C12 stereochemistry found in pleuromutilin and was elaborated to an alkynylaldehyde. Nickel-catalyzed reductive cyclization of this alkynylaldehyde, to construct the eight-membered ring of the target, unexpectedly provided a cyclopentene (67%), which arises from participation of the C12-α-olefin in the transformation. The diketone derived from the enantiomeric C12-fragment (R)-30 underwent reductive cyclization to provide the desired product in 60% yield. This was elaborated to 12-epi-mutilin by a four-step sequence (39% overall). Installation of the glycolic acid residue followed by C12 epimerization (Berner et al. Monatsh. Chem. 1986, 117, 1073) generated (+)-pleuromutilin (1). (+)-12-epi-Pleuromutilin and (+)-11,12-di-epi-pleuromutilin were prepared by related sequences. This work establishes a convergent entry to the pleuromutilins and provides a foundation for the production of novel antibiotics to treat drug-resistant and Gram-negative infections.
机译:我们描述了对(+)-胸膜胃泌素(1),(+)-12-表皮-胃泌素和相关衍生物的对映选择性合成途径的发展。分三步制备了关键的氢化丹酮,环己-2-烯-1-酮的总产率为48%。 1,4-氢氰化提供了腈(基于回收的起始原料,为53%或85%),通过将1,2-甲基锂加到腈官能团,环化反应中以及用二碳酸二叔丁酯原位酰化。烯酰亚胺57与衍生自烷基碘(R)-或(S)-30的有机锂试剂进行2倍新戊基偶联反应,该烷基碘包含目标的C11-C13原子,以提供60的非对映二酮%或48%的产率(分别用于与(R)-或(S)-30偶联)。衍生自(S)-30的二酮含有在截短侧耳素中发现的(S)-C12立体化学,并被精制为炔醛。镍炔醛的镍催化还原环化反应可构建目标的八元环,出乎意料地提供了环戊烯(67%),该环戊烯是由C12-α-烯烃参与转化而产生的。衍生自对映体C12片段(R)-30的二酮经过还原环化以60%的收率提供所需产物。通过四个步骤将其精制为12-表皮-短纤蛋白(总含量39%)。乙醇酸残基的安装,接着C12差向异构化(Berner等人,Monatsh.Chem.1986,117,1073)产生了(+)-胸膜鹦鹉螺菌素(1)。通过相关序列制备(+)-12-表皮侧耳素和(+)-11,12-二-表皮侧耳素。这项工作建立了截短侧耳素的融合入口,并为生产新型抗生素治疗耐药性和革兰氏阴性感染提供了基础。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2017年第45期|16377-16388|共12页
  • 作者单位

    Department of Chemistry, Yale University, New Haven, CT, United States;

    Department of Chemistry, Yale University, New Haven, CT, United States;

    Department of Chemistry, Yale University, New Haven, CT, United States,Department of Pharmacology, Yale School of Medicine, New Haven, CT, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号